Literature DB >> 22760350

Short-term treatment of catatonia with amantadine in schizophrenia and schizoaffective disorder.

David Freitas de Lucena, Joel Porfirio Pinto, Jaime E Hallak, José Alexandre Crippa, Clarissa Severino Gama.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22760350     DOI： 10.1097/JCP.0b013e31825ebf6e

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  4 in total

Review 1.  A clinical review of the treatment of catatonia.

Authors:  Pascal Sienaert; Dirk M Dhossche; Davy Vancampfort; Marc De Hert; Gábor Gazdag
Journal:  Front Psychiatry       Date:  2014-12-09       Impact factor: 4.157

Review 2.  Systematic review of catatonia treatment.

Authors:  Anne Cm Pelzer; Frank Mma van der Heijden; Erik den Boer
Journal:  Neuropsychiatr Dis Treat       Date:  2018-01-17       Impact factor: 2.570

3.  Associations Between Amantadine Usage, Gait, and Cognition in PSP: A post-hoc Analysis of the Davunetide Trial.

Authors:  Marian L Dale; Barbara H Brumbach; Adam L Boxer; Amie L Hiller
Journal:  Front Neurol       Date:  2020-12-21       Impact factor: 4.003

Review 4.  Molecular and cellular mechanisms leading to catatonia: an integrative approach from clinical and preclinical evidence.

Authors:  Daniel Felipe Ariza-Salamanca; María Gabriela Corrales-Hernández; María José Pachón-Londoño; Isabella Hernández-Duarte
Journal:  Front Mol Neurosci       Date:  2022-09-29       Impact factor: 6.261
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.